In view of a previous report of decreased HLA class I expression on monocytes and B cells in patients with MS [20], which could impair the generation and effector function of EBV-specific CD8+ T cells, we have undertaken the present study to quantify the level of HLA expression on B cells and monocytes in MS patients and healthy subjects. This evidence concerns the gene CD8A and myeloid sarcoma.